BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 12724780)

  • 1. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
    Ueda H; Howson JM; Esposito L; Heward J; Snook H; Chamberlain G; Rainbow DB; Hunter KM; Smith AN; Di Genova G; Herr MH; Dahlman I; Payne F; Smyth D; Lowe C; Twells RC; Howlett S; Healy B; Nutland S; Rance HE; Everett V; Smink LJ; Lam AC; Cordell HJ; Walker NM; Bordin C; Hulme J; Motzo C; Cucca F; Hess JF; Metzker ML; Rogers J; Gregory S; Allahabadia A; Nithiyananthan R; Tuomilehto-Wolf E; Tuomilehto J; Bingley P; Gillespie KM; Undlien DE; Rønningen KS; Guja C; Ionescu-Tîrgovişte C; Savage DA; Maxwell AP; Carson DJ; Patterson CC; Franklyn JA; Clayton DG; Peterson LB; Wicker LS; Todd JA; Gough SC
    Nature; 2003 May; 423(6939):506-11. PubMed ID: 12724780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
    Kotsa K; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
    Heward JM; Allahabadia A; Carr-Smith J; Daykin J; Cockram CS; Gordon C; Barnett AH; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
    Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL
    Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
    Kouki T; Gardine CA; Yanagawa T; Degroot LJ
    J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?
    Kristiansen OP; Larsen ZM; Pociot F
    Genes Immun; 2000 Feb; 1(3):170-84. PubMed ID: 11196709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autoimmune disease-associated CTLA4 splice variant lacking the B7 binding domain signals negatively in T cells.
    Vijayakrishnan L; Slavik JM; Illés Z; Rainbow D; Peterson LB; Sharpe AS; Wicker LS; Kuchroo VK
    Novartis Found Symp; 2005; 267():200-12; discussion 212-8. PubMed ID: 15999808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
    Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
    Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.
    Kikuoka N; Sugihara S; Yanagawa T; Ikezaki A; Kim HS; Matsuoka H; Kobayashi Y; Wataki K; Konda S; Sato H; Miyamoto S; Sasaki N; Sakamaki T; Niimi H; Murata M
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):597-603. PubMed ID: 11894970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
    Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
    Nithiyananthan R; Heward JM; Allahabadia A; Franklyn JA; Gough SC
    Thyroid; 2002 Jan; 12(1):3-6. PubMed ID: 11842815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry.
    Nisticò L; Buzzetti R; Pritchard LE; Van der Auwera B; Giovannini C; Bosi E; Larrad MT; Rios MS; Chow CC; Cockram CS; Jacobs K; Mijovic C; Bain SC; Barnett AH; Vandewalle CL; Schuit F; Gorus FK; Tosi R; Pozzilli P; Todd JA
    Hum Mol Genet; 1996 Jul; 5(7):1075-80. PubMed ID: 8817351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 and its role in autoimmune thyroid disease.
    Chistiakov DA; Turakulov RI
    J Mol Endocrinol; 2003 Aug; 31(1):21-36. PubMed ID: 12914522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
    Bergholdt R; Taxvig C; Eising S; Nerup J; Pociot F
    J Leukoc Biol; 2005 Apr; 77(4):579-85. PubMed ID: 15629882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
    Blomhoff A; Kemp EH; Gawkrodger DJ; Weetman AP; Husebye ES; Akselsen HE; Lie BA; Undlien DE
    Pigment Cell Res; 2005 Feb; 18(1):55-8. PubMed ID: 15649153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies.
    Vaidya B; Pearce S
    Eur J Endocrinol; 2004 May; 150(5):619-26. PubMed ID: 15132716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
    Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
    Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
    Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese.
    Furugaki K; Shirasawa S; Ishikawa N; Ito K; Ito K; Kubota S; Kuma K; Tamai H; Akamizu T; Hiratani H; Tanaka M; Sasazuki T
    J Hum Genet; 2004; 49(3):166-168. PubMed ID: 14986169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.